Literature DB >> 11723184

Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices.

Q S Yan1, S E Yan.   

Abstract

In order to assess a role of 5-HT(1B) receptors for regulation of GABA transmission in the ventral tegmental area (VTA), VTA slices from the rat were incubated with [(3)H]GABA and beta-alanine, and superfused in the presence of nipecotic acid and aminooxyacetic acid. [(3)H]GABA release was induced by exposures to the medium containing 30 mM potassium for 2 min. The results showed that high potassium-evoked [(3)H]GABA release was sensitive to calcium withdrawal or blockade of sodium channels by tetrodotoxin, suggesting that tritium overflow induced by high potassium derived largely from neuronal stores. Administration of CP 93129 (0.15 and 0.45 microM), a 5-HT(1B) receptor agonist, or RU 24969 (0.15 and 0.45 microM), a 5-HT(1B/1A) receptor agonist, but not 8-OH-DPAT (0.45 microM), a 5-HT(1A) receptor agonist, inhibited high potassium-evoked [(3)H]GABA release in a concentration-related manner. The RU 24969-induced inhibition of [(3)H]GABA release was antagonized by either SB 216641, a 5-H(1B) receptor antagonist, or cyanopindolol, a 5-HT(1B/1A) receptor antagonist, but not by WAY 100635, a 5-HT(1A) receptor antagonist. Pre-treatment with SB 216641 also antagonized CP 93129-induced inhibition of [(3)H]GABA release. The results support the hypothesis that 5-HT(1B) receptors within the VTA can function as heteroreceptors to inhibit GABA release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723184     DOI: 10.1046/j.1471-4159.2001.00643.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  Serotonin and prefrontal cortex function: neurons, networks, and circuits.

Authors:  M Victoria Puig; Allan T Gulledge
Journal:  Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.590

2.  Serotonin 1B receptor imaging in pathological gambling.

Authors:  Marc N Potenza; Espen Walderhaug; Shannan Henry; Jean-Dominique Gallezot; Beata Planeta-Wilson; Jim Ropchan; Alexander Neumeister
Journal:  World J Biol Psychiatry       Date:  2011-09-22       Impact factor: 4.132

3.  Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe.

Authors:  Julia C Lemos; Yu-Zhen Pan; Xiaohong Ma; Christophe Lamy; Adaure C Akanwa; Sheryl G Beck
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

Review 4.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

Review 5.  Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity.

Authors:  Robert F Leeman; Marc N Potenza
Journal:  Psychopharmacology (Berl)       Date:  2011-11-05       Impact factor: 4.530

6.  5-HT1B mRNA expression after chronic social stress.

Authors:  Amy R Furay; Ross A McDevitt; Klaus A Miczek; John F Neumaier
Journal:  Behav Brain Res       Date:  2011-06-21       Impact factor: 3.332

7.  Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.

Authors:  Dane Aronsen; Natasha Bukholt; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

8.  Does Serotonin Play a Role in Epilepsy?

Authors:  William H. Theodore
Journal:  Epilepsy Curr       Date:  2003-09       Impact factor: 7.500

9.  Stimulation of 5-HT(1B) receptors enhances cocaine reinforcement yet reduces cocaine-seeking behavior.

Authors:  Nathan S Pentkowski; Jazmin I Acosta; Jenny R Browning; Elizabeth C Hamilton; Janet L Neisewander
Journal:  Addict Biol       Date:  2009-07-24       Impact factor: 4.280

10.  Pairing mild stress with increased serotonin-1B receptor expression in the nucleus accumbens increases susceptibility to amphetamine.

Authors:  Susan M Ferguson; Nolan A Sandygren; John F Neumaier
Journal:  Eur J Neurosci       Date:  2009-10-08       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.